Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 07 - 29 tags : Fda save search
TransMedics Receives FDA Clearance of OCS Lung Solution for Cold Preservation of Lungs
Published: 2021-07-29 (Crawled : 23:00) - prnewswire.com
TMDX M | $84.18 -3.51% -3.64% 960K
|
Health Technology
|
| O: -1.06%
H: 4.08%
C: -1.28%
lungs fda clearance fda clearance
Dicerna Announces FDA Clearance of Investigational New Drug (IND) Application for DCR-AUD for the Treatment of Alcohol Use Disorder
Published: 2021-07-29 (Crawled : 21:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.49%
H: 0.26%
C: -0.62%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.4%
H: 0.3%
C: -0.88%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -0.01%
H: 1.3%
C: -0.14%
new drug alcohol use disorder fda clearance treatment fda drug application clearance
Ardelyx Receives Complete Response Letter from U.S. FDA for New Drug Application for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis
Published: 2021-07-29 (Crawled : 21:00) - biospace.com/
ARDX | $6.5 0.93% 0.92% 5.6M
|
Health Technology
|
| O: 0.58%
H: 2.3%
C: -1.72%
new drug fda drug tenapanor dialysis
Arrowhead Pharmaceuticals Receives Breakthrough Therapy Designation from U.S. FDA for ARO-AAT for the Treatment of Alpha-1 Antitrypsin Deficiency Associated Liver Disease
Published: 2021-07-29 (Crawled : 20:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.0%
H: 0.06%
C: -1.17%
ARWR | $22.33 -1.24% -1.25% 960K
|
Health Technology
|
| O: 1.95%
H: 1.82%
C: -1.98%
disease liver disease treatment fda therapy breakthrough therapy liver designation
FDA Approves Expanded BOTOX® (onabotulinumtoxinA) Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity
Published: 2021-07-29 (Crawled : 20:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.4%
H: 0.08%
C: -0.13%
fda fda approval
FDA broadens existing emergency use of Lilly and Incyte's baricitinib in patients hospitalized with COVID-19 requiring oxygen
Published: 2021-07-29 (Crawled : 17:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.4%
H: 0.3%
C: -0.88%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.64%
H: 0.14%
C: -1.41%
covid baricitinib fda oxygen merge
Future of AstraZeneca’s Vaccine Business is Murky, But Seeks to Move Ahead with FDA Filing
Published: 2021-07-29 (Crawled : 15:15) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.69%
H: 0.08%
C: -0.33%
fda vaccine
New Day For Diabetes Patients As FDA Approves First-Ever Interchangeable Biosimilar
Published: 2021-07-29 (Crawled : 14:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.69%
H: 0.08%
C: -0.33%
diabetes fda fda approval biosimilar
New Day For Diabetes Patients As FDA Approves First-Ever Interchangeable Bios...
Published: 2021-07-29 (Crawled : 14:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.69%
H: 0.08%
C: -0.33%
diabetes fda fda approval
Everest Medicines Receives Pediatric and Rare Severe Disease Priority Review Designation from Taiwan FDA for Sacituzumab Govitecan-Hziy in Metastatic Triple-Negative Breast Cancer
Published: 2021-07-29 (Crawled : 11:00) - prnewswire.com
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.27%
H: 0.21%
C: -0.6%
disease fda cancer breast cancer designation rare
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.